Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine and AmBisome for Visceral Leishmaniasis
NCT00370825Phase 2Completed
- Sponsor
- Banaras Hindu University
- Start
- Sep 2006
- Modality
- Lipid-based Nanoparticles, Nucleic Acid-Directed Small Molecules, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine, liposomal amphotericin b in visceral leishmaniasis (VL), sponsored by Banaras Hindu University. Started Sep 2006; status: completed.
02
Drugs
miltefosineliposomal amphotericin b
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00370825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370825.